A γGT-AT1A receptor transgene protects renal cortical structure in AT1 receptor-deficient mice

Physiological Genomics

Volumn 18, Issue , 2004, Pages 290-298

  Le, Thu H ^a   Oliverio, Michael I ^a   Kim, Hyung Suk ^b   Salzler, Harmony ^a   Dash, Rajesh C ^a   Howell, David N ^a   Smithies, Oliver ^b   Bronson, Sarah ^c   Coffman, Thomas M ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Blood pressure; Glomerular cysts; Proximal tubule

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; GAMMA GLUTAMYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RENIN; SODIUM; HYBRID PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEVELOPMENT; GENE DISRUPTION; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENE TARGETING; HYPOTENSION; KIDNEY CORTEX; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; KIDNEY STRUCTURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR GENE; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE; X CHROMOSOME; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHEMISTRY; GENETIC MARKER; GENETICS; KIDNEY CONCENTRATING CAPACITY; METABOLISM; METHODOLOGY; PHYSIOLOGY; SURVIVAL;

ANIMALIA; INSERTION SEQUENCES; MURINAE; MUS MUSCULUS; TRIXIS;

ANIMALS; BLOOD PRESSURE; GAMMA-GLUTAMYLTRANSFERASE; GENE TARGETING; GENETIC MARKERS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; KIDNEY CONCENTRATING ABILITY; KIDNEY CORTEX; KIDNEY TUBULES, PROXIMAL; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); RECEPTOR, ANGIOTENSIN, TYPE 1; RECOMBINANT FUSION PROTEINS; RENIN; RNA, MESSENGER; SURVIVAL; TRANSGENES; X CHROMOSOME;

EID: 16544364077     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00120.2003     Document Type: Article

References (60)

1. Aguilera G. Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol 90: 53-60, 1992.
2. Ballermann B, Zeidel M, Gunning M, and Brenner B. Vasoactive peptides and the kidney. In: The Kidney (4th ed.), edited by Brenner BM and Rector FC Jr. Philadelphia: Saunders, 1991, p. 510-583.
3. Barr M Jr and Cohen MM Jr. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 44: 485-495, 1991.
4. Benetos A and Safar ME. Aortic collagen, aortic stiffness, and AT1 receptors in experimental and human hypertension. Can J Physiol Pharmacol 74: 862-866, 1996.
5. Briggs JP, Lorenz JN, Weihprecht H, and Schnermann J. Macula densa control of renin secretion. Renal Physiol Biochem 14: 164-174, 1991.
6. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, and Smithies O. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93: 9067-9072, 1996.
7. Chapman AB, Johnson A, Gabow PA, and Schrier RW. The renin-angiotensin- aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323: 1091-1096, 1990.
8. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, and Ichikawa I. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol Renal Physiol 272: F299-F304, 1997.
9. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15: 451-458, 1990.
10. Cogan MG, Xie MH, Liu FY, Wong PC, and Timmermans PB. Effects of DuP 753 on proximal nephron and renal transport. Am J Hypertens 4: 315S-320S, 1991.
11. Cunniff C, Jones KL, Phillipson J, Benirschke K, Short S, and Wujek J. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use. Am J Obstet Gynecol 162: 187-189, 1990.
12. Davisson RL, Oliverio MI, Coffman TM, and Sigmund CD. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 106: 103-106, 2000.
13. Earley LE and Schrier RW. Intrarenal control of sodium excretion by hemodynamics and physical factors. In: Handbook of Renal Physiology. Renal Physiology. Washington, DC: Am. Physiol. Soc., 1973, sect. 8, chapt. 22, p. 721-762.
14. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, and Bernstein KE. Mice lacking ahgiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74: 953-965, 1996.
15. Faubert PF, Chou SY, and Porush JG. Regulation of papillary plasma flow by angiotensin II. Kidney Int 32: 472-478, 1987.
16. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, and Adams M. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485-492, 1994.
17. Gordon JW. Production of transgenic mice. Methods Enzymol 225: 747-771, 1993.
18. Griendling K, Lassegue B, and Alexander R. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 36: 281-306, 1996.
19. Guyton AC, Coleman TG, Cowley AW Jr, Scheel KW, Manning RD Jr, and Norman RA, Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52: 584-594, 1972.
20. Hall J, Guyton A, Trippodo N, Lohmeier T, McCaa R, and Cowley A. Intrarenal control of electrolyte excretion by angiotensin II. Am J Physiol Renal Fluid Electrolyte Physiol 232: F538-F544, 1977.
21. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol Regul Integr Comp Physiol 250: R960-R972, 1986.
22. Harrap SB, Davies DL, Macnicol AM, Dominiczak AF, Fraser R, Wright AF, Watson ML, and Briggs JD. Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int 40: 501-508, 1991.
23. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol Renal Physiol 273: F170-F177, 1997.
24. Healy DP, Ye MQ, and Troyanovskaya M. Localization of angiotensin II type 1 receptor subtype mRNA in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 268: F220-F226, 1995.
25. Hein L, Stevens ME, Barsh GS, Pratt RE, Kobilka BK, and Dzau VJ. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci USA 94: 6391-6396, 1997.
26. Ichikawa I and Brenner B. Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. J Clin Invest 65: 1192-1201, 1980.
27. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, and Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92: 3521-3525, 1995.
28. Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T, and Ichikawa I. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47: 140-147, 1995.
29. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, and Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92: 2735-2739, 1995.
30. Kim HS, Lee G, John SW, Maeda N, and Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc Natl Acad Sci USA 99: 4602-4607, 2002.
31. Kojima I, Kojima K, Kruetter K, and Rasmussen H. The temporal integration of the aldosterone secretory response occurs via two intracellular pathways. J Biol Chem 259: 14448, 1984.
32. Krege J, Hodgin J, Hagaman J, and Smithies O. A computerized system for measuring blood pressure in mice. Hypertension 25: 1111-1115, 1995.
33. Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, Takekoshi N, Murakami K, Kadowaki T, and Yazaki Y. Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice. J Biol Chem 273: 24037-24043, 1998.
34. Kumar D, Moss G, Primhak R, and Coombs R. Congenital renal tubular dyspfasia and skull ossification defects similar to teratogenic effects of angiotensin convening enzyme (ACE) inhibitors. J Med Genet 34: 541-545, 1997.
35. Laghmani K, Preisig PA, Moe OW, Yanagisawa M, and Alpern RJ. Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis. J Clin Invest 107: 1563-1569, 2001.
36. Levine DZ, Iacovitti M, Buckman S, and Burns KD. Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J Clin Invest 97: 120-125, 1996.
37. Matsusaka T, Nakazato H, Takaya J, Katori H, Kon V, Fogo A, and Ichikawa A. Vascular hypertrophy in dual renin null mutant mice (Abstract). J Am Soc Nephrol 10: 350, 1999.
38. Miyazaki Y, Tsuchida S, Nishimura H, Pope JC IV, Harris RC, McKanna JM, Inagami T, Hogan BL, Fogo A, and Ichikawa I. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 102: 1489-1497, 1998.
39. Navar L, Carmines P, Huang WC, and Mitchell K. The tubular effects of angiotensin II. Kidney Int 31: S81-S88, 1987.
40. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, and Inagami T. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96: 2947-2954, 1995.
41. 1B receptors for angiotensin II. Proc Natl Acad Sci USA 95: 15496-15501, 1998.
42. Oliverio MI, Best CF, Smithies O, and Coffman TM. Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. Hypertension 35: 550-554, 2000.
43. Oliverio MI, Delnomdedieu M, Best CF, Li P, Morris M, Callahan MF, Johnson GA, Smithies O, and Coffman TM. Abnormal water metabolism in mice lacking the type IA receptor for ANG II. Am J Physiol Renal Physiol 278: F75-F82, 2000.
44. Orsen WM, Berry CA, and Rector FC. Renal Transport of Glucose, Amino Acids, Sodium, Chloride, and Water. Philadelphia: Saunders, 2000.
45. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, and Nemer M. Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA 97: 931-936, 2000.
46. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW, and Bernstein KE. Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol Renal Fluid Electrolyte Physiol 264: F989-F995, 1993.
47. Peach M. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370, 1977.
48. Rajagopalan S, Wan DF, Habib G, Sepulveda A, McLeod M, Lebovitz R, and Lieberman M. Six mRNAs with different 5′ ends are encoded by a single γ-glutamyltransferase gene in mouse. Proc Natl Acad Sci USA 90: 6179-6183, 1993.
49. Reid LH, Shesely EG, Kim HS, and Smithies O. Cotransformation and gene targeting in mouse embryonic stem cells. Mol Cell Biol 11: 2769-2777, 1991.
50. Ruan X, Wagner C, Chatziantoniou C, Kurtz A, and Arendshorst W. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest 99: 1072-1081, 1997.
51. Schaffner D, Barrios R, Massey C, Banez E, Ou CN, Rajagopaian S, Agullar-Cordova E, Lebovitz R, Overbeek P, and Lieberman M. Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 142: 1051-1060, 1993.
52. Schlatter E, Haxelmans S, Ankorina I, and Kleta R. Regulation of Na+/H+ exchange by diadenosine polyphosphates, angiotensin II, and vasopressin in rat cortical collecting duct. J Am Soc Nephrol 6: 1223-1229, 1995.
53. Schnermann JB, Traynor T, Yang T, Huang YG, Oliverio MI, Coffman T, and Briggs JP. Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. Am J Physiol Renal Physiol 273: F315-F320, 1997.
54. Schuster VL, Kokko JP, and Jacobson HR. Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 73: 507-515, 1984.
55. Timmermans P, Wong P, Chiu A, Herblin W, Benfield P, Carini D, Lee R, Wexler R, Saye J, and Smith R. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
56. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, and Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998.
57. Tufro-McReddie A, Johns D, Geary K, Dagli H, Everett A, Chevalier R, Carey R, and Gomez R. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am J Physiol Renal Fluid Electrolyte Physiol 266: F911-F918, 1994.
58. Wang T and Giebisch G. Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 271: F143-FI49, 1996.
59. Xie MH, Liu FY, Wong P, Timmermans P, and Cogan M. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist. Kidney Int 38: 473-479, 1990.
60. Yababa M, Umemura S, Kihara M, Tamura K, Nyui N, Ishigami T, Ishii M, Kiuchi Y, Yagami K, Tanimoto K, Sugiyama F, Fukamizu A, and Murakami K. Altered development of vasculature in the kidney but not in other main organs in angiotensinogen-deficient mice (Abstract). Hypertension 28: 543, 1996.